Medexus Pharmaceuticals Inc.
MEDXF
Price:
$2.89
Market Cap:
$92.01M
Medexus Pharmaceuticals Inc. is a specialized pharmaceutical firm conducting operations across both Canada and the United States. The company's therapeutic focus spans several critical domains, including cancer treatment (oncology), blood disorders (hematology), joint and muscle conditions (rheumatology), autoimmune disorders, and allergic reactions. Among its leading offerings are Rasuvo and Metoject, both methotrexate formulations specifically developed for managing rheumatoid arthritis and various autoimmune conditions. Another significant product is IXINITY, an intravenous recombinant factor IX therapy prescribed for individuals aged 12 and above suffering from Hemophilia B. Additionally...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-11-27
Stock Exchange
OTC
Ticker
MEDXF
PE Ratio
[-144.50]
ROE
[-0.52%]
Current Ratio
[1.12]
Dividend Yield
[0%]
Enterprise Value
[102.39M]
Dividend History
The ROE as of June 2026 (TTM) for Medexus Pharmaceuticals Inc. (MEDXF) is -0.52%
According to Medexus Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current ROE is -0.52%. This represents a change of 288.61% compared to the average of -0.13% of the last 4 quarters.
Medexus Pharmaceuticals Inc. (MEDXF) Historical ROE (quarterly & annually)
How has MEDXF ROE performed in the past?
The mean historical ROE of Medexus Pharmaceuticals Inc. over the last ten years is -53.44%. The current -0.52% ROE has changed -99.03% with respect to the historical average. Over the past ten years (40 quarters), MEDXF's ROE was at its highest in in the September 2018 quarter at 249.78%. The ROE was at its lowest in in the December 2020 quarter at -233.12%.
Average
-53.44%
Median
-17.77%
Minimum
-156.87%
Maximum
5.44%
Medexus Pharmaceuticals Inc. (MEDXF) ROE by Quarter and Year
Discovering the peaks and valleys of Medexus Pharmaceuticals Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 710.21%
Maximum Annual ROE = 5.44%
Minimum Annual Increase = -710.61%
Minimum Annual ROE = -156.87%
| Year | ROE | Change |
|---|---|---|
| 2025 | 4.31% | -710.61% |
| 2024 | -0.71% | -112.97% |
| 2023 | 5.44% | -133.61% |
| 2022 | -16.18% | -89.68% |
| 2021 | -156.87% | 710.21% |
| 2020 | -19.36% | 48.31% |
| 2019 | -13.05% | -88.61% |
| 2018 | -114.64% | -18.92% |
| 2017 | -141.39% | 72.60% |
| 2016 | -81.92% | -6.72% |
Medexus Pharmaceuticals Inc. (MEDXF) Average ROE
How has MEDXF ROE performed in the past?
The current ROE of Medexus Pharmaceuticals Inc. (MEDXF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.01%
5-year avg
-32.80%
10-year avg
-53.44%
Medexus Pharmaceuticals Inc. (MEDXF) ROE vs. Peers
How is MEDXF’s ROE compared to its peers?
Medexus Pharmaceuticals Inc.’s ROE is greater than Planet 13 Holdings Inc. (-112.30%), greater than Decibel Cannabis Company Inc. (-5.10%), less than Earth Science Tech, Inc. (73.99%), less than Flower One Holdings Inc. (831.59%), greater than TransCanna Holdings Inc. (-239.59%), less than Precision System Science Co., Ltd. (3.52%), less than 1CM Inc. (14.31%), greater than Radnostix, Inc. (-24706209.67%), greater than Vext Science, Inc. (-25.19%), greater than Nicox S.A. (-51.16%),
| Company | ROE | Market cap |
|---|---|---|
| -112.30% | $41.40M | |
| -5.10% | $48.62M | |
| 73.99% | $49.54M | |
| 831.59% | $4.73K | |
| -239.59% | $11.97K | |
| 3.52% | $62.00M | |
| 14.31% | $17.05M | |
| -24706209.67% | $37.04M | |
| -25.19% | $45.33M | |
| -51.16% | $30.94M |
Build a custom stock screener for Medexus Pharmaceuticals Inc. (MEDXF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medexus Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Medexus Pharmaceuticals Inc. (MEDXF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Medexus Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Medexus Pharmaceuticals Inc.'s ROE?
How is the ROE calculated for Medexus Pharmaceuticals Inc. (MEDXF)?
What is the highest ROE for Medexus Pharmaceuticals Inc. (MEDXF)?
What is the 3-year average ROE for Medexus Pharmaceuticals Inc. (MEDXF)?
What is the 5-year average ROE for Medexus Pharmaceuticals Inc. (MEDXF)?
How does the current ROE for Medexus Pharmaceuticals Inc. (MEDXF) compare to its historical average?